Quest Diagnostics will integrate a 50-biomarker lab test panel into the Apple Health app, allowing US users to order ...

Quest Diagnostics (NYSE: DGX) today announced that Apple Health app users in the United States1 will be able to conveniently purchase a tailored Quest laboratory test panel that includes over 50 ...

Quest Diagnostics launched a direct-to-consumer service that allows users to order and pay for lab tests from home. Dubbed QuestDirect, the online service offers 35 diagnostic test packages covering ...

In recent months, Renalytix PLC, Humanity Health Inc., and Quest Diagnostics have announced new collaborations and product ...

Though countless diagnostic developers struck it rich at the height of the COVID-19 pandemic, many of those that were relatively new to the testmaking game are now struggling to make up for lost sales ...

Quest Diagnostics has introduced a new flow cytometry measurable residual disease (MRD) blood test for myeloma, a cancer arising from abnormal plasma cells. The test aims to enhance ultra-sensitive ...

Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...

Quest Diagnostics has a strong Q2 with a slight beat on EPS and revenue. Quest’s base business appears to be recovering from the pandemic and pulled in $2.30B in revenue. Despite fading COVID-related ...

Our indicative theme of Covid-19 Testing Stocks– which includes the stocks of companies that produce or carry out tests for the highly infectious virus – is up by about 51% year-to-date, on an equally ...